COMPOUNDS FOR TREATING NEUROPSYCHIATRIC CONDITIONS
申请人:Campbell David
公开号:US20120046283A1
公开(公告)日:2012-02-23
Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of neuropsychiatric conditions.
本文提供了PAK抑制剂及其在治疗神经精神疾病方面的应用方法。
METHODS FOR TREATING ALZHEIMER'S DISEASE
申请人:Lichter Jay
公开号:US20120270844A1
公开(公告)日:2012-10-25
Provided herein arc PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from Alzheimer's disease.
本文提供了PAK抑制剂。同时还提供了治疗患有阿尔茨海默病个体的组合物和方法。
8-(SULFONYLBENZYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
申请人:Campbell David
公开号:US20130252967A1
公开(公告)日:2013-09-26
Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders.
本文提供了PAK抑制剂及其在治疗中枢神经系统疾病方面的应用方法。
PAK INHIBITORS FOR THE TREATMENT OF CANCER
申请人:Afraxis, Inc.
公开号:US20130158043A1
公开(公告)日:2013-06-20
Provided herein are methods of utilizing PAK inhibitors for the treatment of cancer. Further provided herein are compounds and formulations utilized for the treatment of cancer.
本文提供了利用PAK抑制剂治疗癌症的方法。此外,还提供了用于治疗癌症的化合物和配方。
METHODS FOR TREATING AUTISM
申请人:Lichter Jay
公开号:US20130096115A1
公开(公告)日:2013-04-18
Provided herein are PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from autism.